Showing results (151-160 of 316) with videos related to

Sort By:
Pageof 32
Journal of Clinical Apheresis|August 23, 2019
Iron deficiency anemia associated with extracorporeal photopheresis: A retrospective analysisAlexis K Kuhn, Gabriel T Bartoo, Ross A Dierkhising, et al.
Rheumatology (Oxford, England)|May 25, 2023
Targeted testing of bone marrow specimens with cytoplasmic vacuolization to identify previously undiagnosed cases of VEXAS syndromeAlexander S Hines, Matthew J Koster, Allison R Bock, et al.
Leukemia|April 4, 2014
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patientsM M Patnaik, R Itzykson, T L Lasho, et al.
American Journal of Hematology|October 13, 2017
Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMMLMrinal M Patnaik, Rangit Vallapureddy, Fevzi F Yalniz, et al.
American Journal of Hematology|September 9, 2014
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium StudyEmnet A Wassie, Raphael Itzykson, Terra L Lasho, et al.
Leukemia|October 23, 2009
JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survivalA Tefferi, T L Lasho, M M Patnaik, et al.
American Journal of Hematology|February 9, 2018
Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk modelNaseema Gangat, Mythri Mudireddy, Terra L Lasho, et al.
Blood|November 7, 2024
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigmAnthony M Hunter, Mrinal M Patnaik, Raphael Itzykson, et al.
Blood Advances|February 23, 2018
Targeted next-generation sequencing in blast phase myeloproliferative neoplasmsTerra L Lasho, Mythri Mudireddy, Christy M Finke, et al.
Blood|November 19, 2011
SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic valueMrinal M Patnaik, Terra L Lasho, Janice M Hodnefield, et al.
Pageof 32